Besides, CCDC86 has been shown to enhance the metastatic potential of nasopharyngeal carcinoma by up-regulating EGFR and activating the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.12 Here, AKT1 is linked to nasopharyngeal carcinoma.